SHANGHAI, March 27 (Bernama-BUSINESS WIRE) -- Last
October, the Chinese government approved a blueprint called “Healthy
China 2030”, pledging to build a healthy China in the next 15 years. By
2030, the size of the healthcare market is expected to reach $2.3
trillion. This initiative is in line with China’s determination to
deepen the supply-side structural reforms in 2017 by substantially
driving down overcapacity, and increasing efficient supply which call
for stricter standards in healthcare industry. The next 15 years will
see a surge of investment and changes in the industry.
Healthcare China 2017,
organized by Reed Sinopharm Exhibitions (RSE), is a platform for global
investors to discover more about the dynamics of healthcare business in
China. To be held on May 13-14, 2017, at the Pullman
Shanghai, the event will attract corporate leaders, government
regulators, influencers, researchers and entrepreneurs, focusing on
three main areas of investors’ interest—biomedical, medical devices, and
medical services.
CHINA'S HEALTHCARE MARKET TO SEE SURGE OF INVESTMENT AND OPPORTUNITIES IN NEXT 15 YEARS
No comments:
Post a Comment